The first domestic anti -new crown oral medicine, the price was initial!

Henan True Biotechnology Co., Ltd. revealed on the 7th that at present, the price of Azf, which treats the new crown pneumonia, is initially determined. Each bottle is less than 300 yuan, 35 tablets per bottle, and 1 mg per piece.

On July 25, the State Drug Administration conducted emergency review and approval in accordance with the relevant provisions of the Drug Management Law in accordance with the relevant provisions of the Drug Management Law. Symptom registration application. This means that Azf's fixed film has become the first newly -developed oral small crown therapy drug in China.

On August 2nd, Azf's fixed film of Henan Real Biotechnology Co., Ltd. was put into production in Pingdingshan. The annual output of the future preparation can reach 3 billion pieces.

Azf's fixed film was approved for listing in July last year as the treatment of AIDS drugs, and was commissioned by real biological commissioned Beijing Xiehe Pharmaceutical Co., Ltd. In May of this year, the real biological Pingdingshan production base successfully passed the medical production quality management specifications organized by the Henan Provincial Pharmaceutical Supervision Bureau in accordance with the compliance inspection, marking that the company's own production bases can comply with the production and operation of drugs. In order to meet the needs of large -scale production, real creatures officially start production.

Earlier, Fosun Pharmaceuticals had reached strategic cooperation with real creatures. The two parties will jointly develop and be exclusively commercialized by the holding subsidiary Fosun Pharmaceutical Industry Azfdin. The cooperation fields include new coronary virus pneumonia, AIDS therapy and prevention. Among them, the production and supply of cooperative products in China is mainly responsible for the production and supply of products in China.

Disclaimer: This article is transferred from Henan Daily (ID: HNRBXMTB), Beijing Youth Daily (ID: Beijingqingnianbao)

- END -